V, G., K, F., S, R., A, G., MJS, D., MJ, E., . . . M, H. (2025). Long-term outcomes of chemoimmunotherapy with obinutuzumab/chlorambucil in chronic lymphocytic leukemia. Blood advances, 9(10), 2431. https://doi.org/10.1182/bloodadvances.2024014875
Chicago Style (17th ed.) CitationV, Goede, et al. "Long-term Outcomes of Chemoimmunotherapy with Obinutuzumab/chlorambucil in Chronic Lymphocytic Leukemia." Blood Advances 9, no. 10 (2025): 2431. https://doi.org/10.1182/bloodadvances.2024014875.
MLA (9th ed.) CitationV, Goede, et al. "Long-term Outcomes of Chemoimmunotherapy with Obinutuzumab/chlorambucil in Chronic Lymphocytic Leukemia." Blood Advances, vol. 9, no. 10, 2025, p. 2431, https://doi.org/10.1182/bloodadvances.2024014875.
Warning: These citations may not always be 100% accurate.